心臟结构植入物：创新和增长机会

本报告考察了全球心臟结构植入物市场，包括市场概况/背景、主要增长驱动因素/制约因素、关键植入物和设备的技术分析、行业分析和增长机会分析。

内容

战略要务

• 增长问题
• 战略要务 8 (TM)
• 三大战略要务的影响
• 增长机会推动增长PipelineEngine (TM)
• 调查方法

增长机会分析

• 结构性心脏病 (SHD) 概述
• 最成熟的心臟瓣膜病介入技术：经皮二尖瓣成形术 (PTMV)
• 心臟结构植入物的分类
• 介入治疗：主要针对有手术风险的患者
• 技术市场分析
• 增长动力
• 抑制增长的因素
• 分析范围

经导管二尖瓣修復/置换 (TMVR) 植入物：技术分析

房间隔缺损 (Tc-ASD) 封堵器：技术分析

行业评估

• 支持 AI 的人工二尖瓣是 TMVR 的未来
• 3D 生物打印，仿生 ASD 封堵器
• 用于 MIS 的心臟结构植入物
• 需要在创新和法规之间取得平衡
• TMVR/TMVr：专利数据库分析
• ASD 关闭装置：专利数据库分析
• 二尖瓣植入物和 ASD 封堵器新技术分析
• 人工智能在成长期心血管植入物中的应用

增长机会领域

• 增长机会：仿生或仿生心臟植入物可减少设备故障
• 增长机会：用于实时心臟参数检索的微电子和支持 AI 的智能植入物
• 发展机会：联合和内部开发使用心臟植入物的可视化技术

附录

下一步

Biomaterials and Design Advances Improve the Efficacy and Safety of Heart Valves and Occluders

Structural heart diseases (SHD) encompass cardiac conditions that cause abnormal blood flow inside the heart's chambers, which can be wrong blood flow direction or blood stagnation. Structural abnormalities in the heart lead to impaired functioning rather than the heart's blood vessels. The cardiovascular implants industry has developed prosthetic valves and occluders to repair structural cardiac defects. This research study analyzes technological innovations in transcatheter mitral valve replacement/repair (TMVr/TMVR) implants and atrial septal defect (ASD) occluders. These implants are evolving to become more biomimetic and intelligent with artificial intelligence (AI)-enabled deployers.

The report also covers the following:

• Industry trends
• Active R&D areas
• Emerging technologies
• Notable stakeholders
• Growth opportunities

Table of Contents

Strategic Imperatives

• Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Structural Heart Implants Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™
• Research Methodology

Growth Opportunity Analysis

• SHD Overview
• Most Prevalent
• Most Well-established Interventional Technique for Valvular Heart Disease: Percutaneous Mitral Valvuloplasty (PTMV)
• PTMV is the Most Well-established Structural Interventional Technique (continued)
• PTMV is the Most Well-established Structural Interventional Technique (continued)
• Structural Heart Implants Segmentation
• Interventional Treatment-Mainly for Patients at Surgical Risk
• Market Analysis of Technologies
• Market Analysis of Technologies (continued)
• Market Analysis of Technologies (continued)
• Market Analysis of Technologies (continued)
• Market Analysis of Technologies (continued)
• Growth Drivers
• Growth Restraints
• Scope of Analysis

Transcatheter Mitral Valves Repair/Replacement Implants-Technology Analysis

• Preference to Mitral Valve Repair over Mitral Valve Replacement
• Mitral Valve Material Analysis
• Mitral Valve Material Analysis (continued)
• Self-expanding Frame of the Valves Generally Comprises Nitinol
• Most-adopted Design Intervention-Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame
• Most-adopted Design Intervention-Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame (continued)
• United States Has the Most Innovations in TMVr/TMVR

Transcatheter Atrial Septal Defect (Tc-ASD) Closure Devices-Technology Analysis

• Tc-ASD can Treat ASD of Septum Secundum
• ASD Material Analysis-Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices
• ASD Material Analysis-Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices (continued)
• Flexible Petal Design Ensures Less Friction Minimizing the Erosion
• Gore Medical Tc-ASDs are FDA Approved and are the Most Successful
• Tc-ASDs Geographical Analysis-United States Has the Most Innovations Dealing with Tc-ASDs

Industry Assessment

• AI-enabled Prosthetic Mitral Valves as the Future of TMVR/TMVr
• 3D-bio-printed, Bio-inspired ASD Occluder is the Future
• Structural Heart Implants for MIS
• Need for Balancing Innovation and Regulation
• Patent Database Analysis for TMVR/TMVr Industry
• Patent Database Analysis for ASD Closure Devices
• Emerging technology Analysis for Mitral Implants and ASD Occluders
• Application of AI in Cardiovascular Implants in the Growth Phase

Growth Opportunity Universe

• Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure
• Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure (continued)
• Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters
• Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters (continued)
• Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants
• Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants (continued)

Appendix

• The Latest Patents Include AI and ML-enabled Intelligent Structural Heart Implants
• Technology Readiness Levels (TRL): Explanation

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• Legal Disclaimer